Search

Author/Creator Watterson, D. Martin

2. First‐in‐Human Studies of MW01‐6‐189WH, a Brain‐Penetrant, Antineuroinflammatory Small‐Molecule Drug Candidate: Phase 1 Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Studies in Healthy Adult Volunteers. Issue 2 (7th April 2020)

Authors:
Van Eldik, Linda J.; Sawaki, Lumy; Bowen, Karen; Laskowitz, Daniel T.; Noveck, Robert J.; Hauser, Byron; Jordan, Lynn; Spears, Tracy G.; Wu, Huali; Watt, Kevin; Raja, Shruti; Roy, Saktimayee M.; Watterson, D. Martin; Guptill, Jeffrey T.
Journal:
Clinical pharmacology in drug development
Issue:
Volume 10:Issue 2(2021)
Page Start:
131
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P2‐129: A Small Molecule Anti‐Neuroinflammatory Experimental Therapeutic Inhibited IL‐1Beta Levels After Traumatic Brain Injury with no Effect on Microglia Physiological Responses. (1st July 2016)

Authors:
Van Eldik, Linda J.; Zhou, Zhengqiu; Watterson, D. Martin; Bachstetter, Adam D.
Journal:
Alzheimer's & dementia
Issue:
Volume 12:Supplement 7S(2016)Part 13
Page Start:
P661
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗